Ocean Biomedical Inc (OCEA)

Currency in USD
0.007
0.000(0.00%)
Closed·
OCEA Scorecard
Full Analysis
Suffers from weak gross profit margins
OCEA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.0070.008
52 wk Range
0.0051.450
Key Statistics
Prev. Close
0.007
Open
0.007
Day's Range
0.007-0.008
52 wk Range
0.005-1.45
Volume
1.17M
Average Volume (3m)
4.01M
1-Year Change
-99.39%
Book Value / Share
-0.66
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
OCEA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to drop this year

Ocean Biomedical Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Buy
Moving Averages
Strong Buy

Ocean Biomedical Inc Company Profile

Ocean Biomedical, Inc., a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases in the United States. The company’s oncology product candidates include OCX-253 anti-Chi3l1 Single-target mAb and OCX-410 anti-Chi3l1/PD-1 Bi-specific antibody for the treatment of non-small cell lung cancer; and OCX-909 anti-Chi3l1/CTLA-4 Bi-specific antibody to treat glioblastoma multiforme. Its fibrosis product candidates consist of OCF-203 anti-Chit1 small molecule for the treatment of idiopathic pulmonary fibrosis (IPF) and hermansky-pudlak syndrome (HPS). The company’s infectious diseases product candidates for malaria include the ODA-570 vaccine for the prevention of P. falciparum infection; ODA-611 anti-PfGARP mAb for the treatment of Symptomatic P. falciparum infection; and ODA-579 anti-PfGARP small molecule for the treatment of Symptomatic P. falciparum infection. It has license agreement with Elkurt, Inc. for FRG Antibody, bi-specific antibody anti-CTLA4, bispecific (FRG)x anti-PD-1 (FRGxPD-1), chit1 small molecule antifibrotic, and malaria small molecules and antibodies. The company was founded in 2019 and is based in Providence, Rhode Island. Ocean Biomedical, Inc. is a subsidiary of Poseidon Bio, LLC.

Compare OCEA to Peers and Sector

Metrics to compare
OCEA
Peers
Sector
Relationship
P/E Ratio
−0.1x−5.2x−0.5x
PEG Ratio
0.000.030.00
Price/Book
0.0x3.8x2.6x
Price / LTM Sales
-241.4x3.2x
Upside (Analyst Target)
-110.3%40.5%
Fair Value Upside
Unlock4.1%4.4%Unlock

Earnings

Latest Release
May 15, 2025
EPS / Forecast
-0.09 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

OCEA Income Statement

People Also Watch

0.5480
NIVF
-0.87%
0.1248
OST
+4.96%
21.88
VERA
-3.31%
0.232
VTAK
+3.11%

FAQ

What Stock Exchange Does Ocean Biomedical Trade On?

Ocean Biomedical is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for Ocean Biomedical?

The stock symbol for Ocean Biomedical is "OCEA."

What Is the Ocean Biomedical Market Cap?

As of today, Ocean Biomedical market cap is 1.70M.

What Is Ocean Biomedical's Earnings Per Share (TTM)?

The Ocean Biomedical EPS (TTM) is -0.71.

From a Technical Analysis Perspective, Is OCEA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Ocean Biomedical Stock Split?

Ocean Biomedical has split 0 times.

How Many Employees Does Ocean Biomedical Have?

Ocean Biomedical has 7 employees.

What is the current trading status of Ocean Biomedical (OCEA)?

As of 25 Jul 2025, Ocean Biomedical (OCEA) is trading at a price of 0.01, with a previous close of 0.01. The stock has fluctuated within a day range of 0.01 to 0.01, while its 52-week range spans from 0.01 to 1.45.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.